Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
Open | $1.200 |
Close | $1.160 |
Volume / Avg. | 13.475K / 129.867K |
Day Range | 1.150 - 1.210 |
52 Wk Range | 0.840 - 2.030 |
Market Cap | $45.753M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 6.49% |
Days to Cover | 16.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bolt Biotherapeutics (NASDAQ: BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Immuneering (NASDAQ:IMRX).
The latest price target for Bolt Biotherapeutics (NASDAQ: BOLT) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 8.00 expecting BOLT to rise to within 12 months (a possible 566.67% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $1.2 last updated April 25, 2024 at 6:55 PM EDT.
A quarterly cash dividend of $0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
Bolt Biotherapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.